# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 16일


## 주요 헤드라인

1. **Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/modernas-fda-challenges-stymie-breakeven-goal-in-fresh-and-fluid-situation>

2. **Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/modernas-fda-challenges-stymie-breakeven-goal-in-fresh-and-fluid-situation>

3. **Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertex-crispr-set-lofty-goal-for-casgevy-gene-therapy-as-patient-starts-ramp>

4. **Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertex-crispr-set-lofty-goal-for-casgevy-gene-therapy-as-patient-starts-ramp>

5. **Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-prepares-1b-orforglipron-stock-ahead-of-approval-as-novo-brings-wegovy-pill-overseas>

6. **Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-prepares-1b-orforglipron-stock-ahead-of-approval-as-novo-brings-wegovy-pill-overseas>

7. **All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/all-eyes-on-vertexs-kidney-franchise-as-painkiller-journavx-tops-half-a-million-scripts>


---
*2026년 02월 16일 바이오스페이스 뉴스 피드에서 생성된 리포트*